Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERSTART
NCT00120185Phase 2Completed
- Sponsor
- ANRS
- Start
- Dec 2003
- Primary completion
- Nov 2006
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aldesleukin in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients reaching an absolute CD4 count below 300/mm3 at 96 weeks. Started Dec 2003; status: completed.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00120185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120185.